```html

Autoimmune Uveitis: What You Need to Know

What is Autoimmune uveitis?

Uveitis is inflammation of the uvea, the middle layer of the eye that includes the iris, ciliary body, and choroid. When the inflammation is caused by the body's own immune system attacking eye tissues, it is called autoimmune uveitis. This type of uveitis is not triggered by infection or trauma; instead, an abnormal immune response mistakenly targets ocular antigens, leading to pain, redness, and visual disturbances.

Autoimmune uveitis can affect one eye (unilateral) or both eyes (bilateral) and may be acute (sudden onset) or chronic (lasting months to years). Prompt recognition and treatment are essential because unchecked inflammation can cause permanent damage to the retina, optic nerve, and other structures, potentially leading to vision loss.

Common Causes

Autoimmune uveitis is often a manifestation of a systemic autoimmune disease. The most frequently associated conditions include:

• Behçet’s disease – a multisystem vasculitis that causes recurring oral/genital ulcers and eye inflammation.
• ankylosing spondylitis – a chronic inflammatory arthritis of the spine that can involve the eye.
• Sarcoidosis – granulomatous disease that frequently affects lungs and lymph nodes, but also the eye.
• Vogt‑Koyanagi‑Harada (VKH) disease – an autoimmune attack on melanocyte‑containing tissues, leading to bilateral uveitis, vitiligo, and meningismus.
• Juvenile idiopathic arthritis (JIA) – the most common cause of uveitis in children.
• Systemic lupus erythematosus (SLE) – can produce intermittent or chronic uveitis.
• Multiple sclerosis (MS) – optic neuritis is classic, but uveitis may coexist.
• Rheumatoid arthritis (RA) – although less common, RA can trigger ocular inflammation.
• Inflammatory bowel disease (Crohn’s disease & ulcerative colitis) – extra‑intestinal manifestations may involve the eye.
• HLA‑B27‑positive seronegative spondyloarthropathies – includes reactive arthritis, psoriatic arthritis, and others.

Associated Symptoms

Because the uvea is richly vascular, inflammation often presents with a combination of ocular and systemic signs:

• Redness of the eye (especially around the cornea)
• Eye pain, which may worsen with bright light (photophobia)
• Blurred or decreased vision
• Floaters (dark spots or threads that drift across the visual field)
• Reduced color perception
• Feeling of “gritty” sensation, as if something is inside the eye
• Headache or scalp tenderness (especially with HLA‑B27 disease)
• Systemic clues: oral/genital ulcers (Behçet’s), joint pain, skin rashes, chronic cough, or neurological symptoms that point to an underlying autoimmune disorder.

When to See a Doctor

Uveitis can progress rapidly. Seek ophthalmologic evaluation promptly if you notice any of the following:

• Sudden onset of eye redness with pain or photophobia.
• New floaters, flashes of light, or a curtain‑like shadow across the vision.
• Unexplained decline in visual acuity, especially if it occurs in both eyes.
• Persistent (more than 24‑48 hours) conjunctival redness that does not improve with over‑the‑counter eye drops.
• Associated systemic symptoms such as fever, joint swelling, oral ulcers, or rash that suggest an autoimmune disease.

Early intervention reduces the risk of complications such as cataract, glaucoma, retinal detachment, or permanent vision loss.

Diagnosis

Diagnosing autoimmune uveitis requires a coordinated approach between an ophthalmologist and, often, a rheumatologist or internist.

Eye‑specific evaluation

• Slit‑lamp examination – magnified view of the anterior segment to detect cells/flare in the anterior chamber.
• Fundoscopy (indirect ophthalmoscopy) – assesses posterior segment inflammation, vasculitis, or choroidal lesions.
• Optical coherence tomography (OCT) – high‑resolution imaging of the retina and macula to detect swelling or fluid.
• Fluorescein angiography – highlights retinal blood‑vessel leakage.
• Ultrasound B‑scan – used when media opacity (e.g., cataract) blocks view of the posterior segment.

Systemic work‑up

• Complete blood count (CBC), erythrocyte sedimentation rate (ESR) and C‑reactive protein (CRP) – markers of inflammation.
• Autoantibody panels: HLA‑B27 typing, ANA, anti‑dsDNA, rheumatoid factor, anti‑CCP, and anti‑ENA.
• Specific disease testing: serum angiotensin‑converting enzyme (ACE) for sarcoidosis, QuantiFERON‑TB Gold for tuberculosis (to rule out infectious uveitis), and chest X‑ray or CT for pulmonary sarcoidosis.
• When indicated, lumbar puncture, MRI of brain/spine, or joint imaging to evaluate systemic disease activity.

Treatment Options

Treatment aims to suppress inflammation, preserve vision, and manage the underlying autoimmune disease.

Medical therapies

• Topical corticosteroids (e.g., prednisolone acetate 1 % eye drops) – first‑line for mild anterior uveitis.
• Cycloplegic agents (e.g., atropine, cyclopentolate) – relieve ciliary spasm and prevent synechiae (adhesions).
• Periocular or intravitreal corticosteroid injections – for intermediate, posterior, or refractory cases.
• Systemic corticosteroids (oral prednisone 0.5–1 mg/kg) – used when inflammation involves the posterior segment or is bilateral.
• Immunomodulatory (steroid‑sparing) agents:
  • Antimetabolites: methotrexate, mycophenolate mofetil, azathioprine.
  • T‑cell inhibitors: cyclosporine, tacrolimus.
  • Biologic agents: adalimumab (TNF‑α inhibitor) – FDA‑approved for non‑infectious uveitis; infliximab, certolizumab, tocilizumab.
• Adjunctive therapy – NSAIDs for pain, intra‑ocular pressure‑lowering drops if steroid‑induced glaucoma develops.

Home & lifestyle measures

• Follow the prescribed eye‑drop schedule exactly; missing doses can trigger flare‑ups.
• Avoid rubbing the eyes; use artificial tears to relieve dryness caused by medication.
• Wear UV‑protective sunglasses to reduce light‑induced discomfort.
• Maintain a balanced diet rich in omega‑3 fatty acids (found in fish, flaxseed) which may modestly help inflammation.
• Quit smoking – smoking worsens autoimmune activity and impairs healing.
• Monitor blood pressure, blood sugar, and liver/kidney function regularly when taking systemic immunosuppressants.

Prevention Tips

While an autoimmune process cannot be eliminated entirely, the risk of flare‑ups can be lowered:

• Adhere strictly to maintenance immunosuppressive therapy even when you feel well.
• Schedule regular ophthalmology and rheumatology follow‑ups; early adjustment of medication can prevent recurrence.
• Promptly treat systemic disease activity (e.g., joint flares, skin lesions) to reduce ocular spill‑over.
• Vaccinations: stay up‑to‑date with influenza, pneumococcal, and COVID‑19 vaccines; infections can trigger immune dysregulation.
• Limit exposure to known triggers such as bright, flickering lights (computer screens, strobe lighting) if they aggravate symptoms.
• Practice good eye hygiene – wash hands before applying eye drops and avoid contaminated lenses.

Emergency Warning Signs

Key Take‑aways

Autoimmune uveitis is a sight‑threatening inflammation driven by systemic immune disorders. Early diagnosis, aggressive inflammation control, and coordinated care between eye specialists and rheumatologists dramatically improve visual outcomes. Patients should be vigilant for red‑eye symptoms, follow treatment plans closely, and seek urgent care for any rapid visual changes.

---

Sources: Mayo Clinic. “Uveitis.”; American Academy of Ophthalmology. “Uveitis Overview.”; National Eye Institute, NIH. “Autoimmune Uveitis.”; CDC. “Behçet’s Disease.”; WHO. “Guidelines for the Management of Non‑Infectious Uveitis.”; Cleveland Clinic. “Biologic Therapies for Uveitis.”; peer‑reviewed articles in *Ophthalmology* and *Arthritis & Rheumatology* (2022‑2024).

```